A New Treatment Era for Light-Chain Amyloidosis:Interprofessional Lessons From a Center of Excellence
1.00 hr(s) | ABIM , CME , CPE , MOC , NCPD
Therapeutic Area(s): Cardiology , Hematology, Benign , Oncology
Release Date: July 9, 2021
Expiration Date: July 8, 2022
Location: Internet Activity Enduring
In this activity, a panel of experts discusses a team-based approach to the management of light chain (AL) amyloidosis. Hear from Suzanne Lentzsch, MD, PhD, Mathew S. Maurer, MD, and Margaret Cuomo, MSN, FNP-C, from the Columbia University Medical Center, as they give insights on diagnostic strategies for AL amyloidosis and as they explore treatment guidelines, evidence, and safety concerns of established and novel approaches to managing AL amyloidosis.